SCHEMBL6003126

SCHEMBL6003126

CC12C[C]3CC(C1)CC(N)(C3)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 4/20 0.50
GRIN2A Q12879 4/20 0.50
LMNA P02545 3/20 0.50
GRIN2D O15399 3/20 0.50
GRIN3B O60391 3/20 0.50
GRIN2B Q13224 3/20 0.50
GRIN2C Q14957 3/20 0.50
GRIN3A Q8TCU5 3/20 0.50
SLC22A1 O15245 2/20 0.50
NFKB1 P19838 2/20 0.50
ESR1 P03372 1/20 0.50
ADRB3 P13945 1/20 0.50
ACHE P22303 1/20 0.50
OPRK1 P41145 1/20 0.50
MTOR P42345 1/20 0.50
HTT P42858 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL327129 0.83 GRIN1 (0.41) GRIN1GRIN2ALMNAGRIN2DGRIN3B
SCHEMBL987369 0.73 GRIN2D (0.31) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL4340088 0.70 MEN1 (0.38) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL4034994 0.69 MEN1 (0.37) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL6229112 0.68 MEN1 (0.37) HTT
Memantine SCHEMBL23327176 0.68 GRIN1 (1.00) GRIN1GRIN2ALMNAGRIN2DGRIN3B
Memantine SCHEMBL8126868 0.68 GRIN1 (1.00) GRIN1GRIN2ALMNAGRIN2DGRIN3B
Memantine SCHEMBL13198606 0.68 GRIN1 (1.00) GRIN1GRIN2ALMNAGRIN2DGRIN3B
SCHEMBL5608589 0.68 GRIN1 (0.90) GRIN1GRIN2ALMNAGRIN2DGRIN3B
Memantine SCHEMBL2688 0.68 GRIN1 (1.00) GRIN1GRIN2ALMNAGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060199816-A1 Aryl sulfonyl piperidines GILLESPIE PAUL 2006-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199816-A1 Aryl sulfonyl piperidines GPR119, SLC5A2, GLS2 GRIN1 3356/4885GRIN2A 2397/4885LMNA 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.